{"id":13,"date":"2014-07-06T14:06:43","date_gmt":"2014-07-06T14:06:43","guid":{"rendered":"http:\/\/3sbrasil.com.br\/?page_id=13"},"modified":"2024-01-10T00:14:26","modified_gmt":"2024-01-10T00:14:26","slug":"certara","status":"publish","type":"page","link":"http:\/\/www.3sbrasil.com.br\/?page_id=13","title":{"rendered":"Sobre a Certara"},"content":{"rendered":"<p class=\"p1\" style=\"text-align: center;\"><a href=\"http:\/\/3sbrasil.com.br\/wp-content\/uploads\/2014\/07\/certara-logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-86\" src=\"http:\/\/3sbrasil.com.br\/wp-content\/uploads\/2014\/07\/certara-logo.png\" alt=\"certara-logo\" width=\"207\" height=\"57\" \/><\/a><\/p>\n<p class=\"p1\" style=\"text-align: center;\"><a href=\"http:\/\/www.3sbrasil.com.br\/wp-content\/uploads\/2014\/07\/image019.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-181\" src=\"http:\/\/www.3sbrasil.com.br\/wp-content\/uploads\/2014\/07\/image019.jpg\" alt=\"\" width=\"730\" height=\"410\" srcset=\"http:\/\/www.3sbrasil.com.br\/wp-content\/uploads\/2014\/07\/image019.jpg 730w, http:\/\/www.3sbrasil.com.br\/wp-content\/uploads\/2014\/07\/image019-300x168.jpg 300w\" sizes=\"auto, (max-width: 730px) 100vw, 730px\" \/><\/a><\/p>\n<p class=\"p1\">Certara was formed by the acquisition of\u00a0Tripos\u00ae,\u00a0Pharsight\u00ae, Simcyp, and Synchrogenix, each with a primary focus on a key phase within the drug discovery and development cycle, to create a single company with a unique\u00a0set of capabilities for modeling, analysis, and simulation that span early discovery through Phase IV clinical trials.<\/p>\n<p class=\"p1\">Today, we are the global leader in biosimulation. Our quantitative science approach and unique portfolio of software and services that span the entire lifecycle accelerate medicines to patients, in concert with you.<\/p>\n<p class=\"p1\">For more information please visit: <a href=\"http:\/\/www.certara.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">http:\/\/www.certara.com\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Certara was formed by the acquisition of\u00a0Tripos\u00ae,\u00a0Pharsight\u00ae, Simcyp, and Synchrogenix, each with a primary focus on a key phase within the drug discovery and development cycle, to create a single company with a unique\u00a0set of capabilities for modeling, analysis, and simulation that span early discovery through Phase IV clinical trials. Today, we are the global [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-13","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/www.3sbrasil.com.br\/index.php?rest_route=\/wp\/v2\/pages\/13","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.3sbrasil.com.br\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.3sbrasil.com.br\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.3sbrasil.com.br\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.3sbrasil.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13"}],"version-history":[{"count":12,"href":"http:\/\/www.3sbrasil.com.br\/index.php?rest_route=\/wp\/v2\/pages\/13\/revisions"}],"predecessor-version":[{"id":191,"href":"http:\/\/www.3sbrasil.com.br\/index.php?rest_route=\/wp\/v2\/pages\/13\/revisions\/191"}],"wp:attachment":[{"href":"http:\/\/www.3sbrasil.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}